INDIANA BLOODWORX
Live / Applied — Second extension granted (statement of use) (as of 21 Feb 2025)
What this means for you
Not registered yet, but its 25 Aug 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97564892
- Mark type
- Stylized text
- Filed
- 25 Aug 2022
- Published for opposition
- 09 Jan 2024
- Attorney of record
- Thomas A. Walsh
Goods and services
- Class 036 — Insurance and financial services: Financial administration of reimbursement programs for pharmaceutical services
Owner
- Indiana Hemophilia and Thrombosis Center, Inc., Indianapolis, IN, US
- Indiana Hemophilia and Thrombosis Center, Inc., Indianapolis, IN, US
Prosecution history
- 22 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Feb 2025 — SOU EXTENSION 2 GRANTED
- 20 Feb 2025 — SOU EXTENSION 2 FILED
- 20 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Feb 2025 — TEAS STATEMENT OF USE RECEIVED
- 15 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Nov 2024 — SOU EXTENSION 1 GRANTED
- 16 Aug 2024 — SOU EXTENSION 1 FILED
- 15 Nov 2024 — DIVISIONAL PROCESSING COMPLETE
- 16 Aug 2024 — DIVISIONAL REQUEST RECEIVED
- 29 Oct 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Aug 2024 — TEAS REQUEST TO DIVIDE RECEIVED
- 16 Aug 2024 — TEAS STATEMENT OF USE RECEIVED
- 15 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 05 Mar 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT